Potter, J L;
Capstick, T;
Ricketts, W M;
Whitehead, N;
Kon, O M;
(2015)
A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB.
Thorax
, 70
(3)
pp. 297-298.
10.1136/Fthoraxjnl-2014-205278.
Preview |
Text
thoraxjnl-2014-205278.pdf Download (330kB) | Preview |
Abstract
Using the best available evidence and expert consensus, this document provides guidance for adverse effect monitoring in multidrug-resistant TB (MDR-TB). It includes recommendations for baseline tests, routine drug and toxicity monitoring guides as well as individual drug monographs for all drugs currently available in the UK to treat TB. These recommendations provide a structure through which healthcare professionals can better manage the complex drug regimens required for the treatment of MDR-TB; minimising the risk of adverse incidents and helping to improve patients' tolerance, compliance and treatment completion.
| Type: | Article |
|---|---|
| Title: | A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1136/Fthoraxjnl-2014-205278 |
| Publisher version: | http://dx.doi.org/10.1136/Fthoraxjnl-2014-205278 |
| Language: | English |
| Additional information: | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/ licenses/by-nc/3.0/. Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/ thoraxjnl-2014-205278) |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1471561 |
Archive Staff Only
 |
View Item |
